Michal Weitman Selected Research

Michal Weitman Research Topics

2	Glioblastoma (Glioblastoma Multiforme) 03/2014 - 06/2012
2	Neoplasms (Cancer) 03/2014 - 06/2012
1	Liver Diseases (Liver Disease) 10/2021
1	Proteostasis Deficiencies 04/2021
1	Infections 01/2021
1	Obesity 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Hyperglycemia 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018
1	Sezary Syndrome (Sezary Erythroderma) 01/2016
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2016
1	Mycosis Fungoides 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2014
1	Glioma (Gliomas) 03/2014
1	Body Weight (Weight, Body) 03/2014
1	Necrosis 06/2012

2	AN1284IBA 10/2021 - 01/2020
2	indolineIBA 01/2020 - 05/2014
2	Butyric Acid (Butanoic Acid)IBA 03/2014 - 06/2012
2	ProdrugsIBA 03/2014 - 06/2012
1	Pharmaceutical PreparationsIBA 04/2021
1	PhloretinIBA 01/2021
1	Acyl-ButyrolactonesIBA 01/2021
1	EnzymesIBA 01/2021
1	AlbuminsIBA 01/2020
1	CreatinineIBA 01/2020
1	PeptidomimeticsIBA 12/2018
1	Vorinostat FDA Link 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	romidepsin (FK228)FDA Link 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	EstersIBA 05/2014
1	Antineoplastic Agents (Antineoplastics)IBA 03/2014
1	AcetaldehydeIBA 06/2012
1	Formaldehyde (Formol)FDA Link 06/2012
1	pivalic acidIBA 06/2012
1	AlaAcBuIBA 06/2012
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2012

1	Drug Therapy (Chemotherapy) 03/2014
1	Therapeutics 06/2012